Comparative Analyses of Disease Risk Genes Belonging to the Acyl-CoA Synthetase Medium-Chain (ACSM) Family in Human Liver and Cell Lines

被引:40
作者
Boomgaarden, Inka [1 ]
Vock, Christina [1 ]
Klapper, Maja [1 ]
Doering, Frank [1 ]
机构
[1] Univ Kiel, Dept Mol Prevent, Inst Human Nutr & Food Sci, D-24118 Kiel, Germany
关键词
Acyl-CoA synthetase medium-chain (ACSM); Medium-chain fatty acid; Liver; HuH-7; HepG2; HUMAN HEPATOCYTES; FATTY-ACIDS; SAH; HYPERTENSION; EXPRESSION; CAUCASIANS; VARIANTS; SEQUENCE; HORMONE; OBESITY;
D O I
10.1007/s10528-009-9273-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human ACSM1, 2A and B, 3, and 5 genes, located on chromosome 16p12-13, encode for enzymes catalyzing the activation of medium-chain length fatty acids. Association studies have linked several polymorphisms of these genes to traits of insulin resistance syndrome. In our study, ACSM transcripts showed 3 to > 400-fold higher expression levels in human liver when compared to cell lines by qRT-PCR. This difference was also evident at the protein level, as shown for ACSM2. In liver, ACSM2 was the most abundant transcript, showing sixfold (vs. ACSM3) to > 300-fold higher expression levels (vs. ACSM1). Mitochondrial localization of the ACSM2 protein and the presence of an N-terminal targeting sequence were shown by GFP-tagging. We have shown ACSM2B to be the predominant transcript in human liver, and genetic variations of this gene could therefore play an important role in disease susceptibility.
引用
收藏
页码:739 / 748
页数:10
相关论文
共 21 条
[1]   Extensive feature detection of N-terminal protein sorting signals [J].
Bannai, H ;
Tamada, Y ;
Maruyama, O ;
Nakai, K ;
Miyano, S .
BIOINFORMATICS, 2002, 18 (02) :298-305
[2]   Overweight, but not hypertension, is associated with SAH polymorphisms in Caucasians with essential hypertension. [J].
Benjafield, AV ;
Iwai, N ;
Ishikawa, K ;
Wang, WYS ;
Morris, BJ .
HYPERTENSION RESEARCH, 2003, 26 (08) :591-595
[3]   Molecular identification and characterization of two medium-chain Acyl-CoA synthetases, MACS1 and the Sa gene product [J].
Fujino, T ;
Takei, YA ;
Sone, H ;
Ioka, RX ;
Kamataki, A ;
Magoori, K ;
Takahashi, S ;
Sakai, J ;
Yamamoto, TT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) :35961-35966
[4]   Two medium-chain acyl-coenzyme A synthetase genes, SAH and MACS1, are associated with plasma high-density lipoprotein cholesterol levels, but they are not associated with essential hypertension [J].
Haketa, A ;
Soma, M ;
Nakayama, T ;
Sato, M ;
Kosuge, K ;
Aoi, N ;
Matsumoto, K .
JOURNAL OF HYPERTENSION, 2004, 22 (10) :1903-1907
[5]   Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells [J].
Harris, AJ ;
Dial, SL ;
Casciano, DA .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 549 (1-2) :79-99
[6]   ISOLATION OF PREFERENTIALLY EXPRESSED GENES IN THE KIDNEYS OF HYPERTENSIVE RATS [J].
IWAI, N ;
INAGAMI, T .
HYPERTENSION, 1991, 17 (02) :161-169
[7]   An acyl-CoA synthetase gene family in chromosome 16p12 may contribute to multiple risk factors [J].
Iwai, N ;
Mannami, T ;
Tomoike, H ;
Ono, K ;
Iwanaga, Y .
HYPERTENSION, 2003, 41 (05) :1041-1046
[8]   Association between SAH, an Acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension [J].
Iwai, N ;
Katsuya, T ;
Mannami, T ;
Higaki, J ;
Ogihara, T ;
Kokame, K ;
Ogata, J ;
Baba, S .
CIRCULATION, 2002, 105 (01) :41-47
[9]   Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes:: A study using adenovirus-mediated antisense targeting [J].
Jover, R ;
Bort, R ;
Gómez-Lechón, MJ ;
Castell, JV .
HEPATOLOGY, 2001, 33 (03) :668-675
[10]   The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population [J].
Lindner, I ;
Rubin, D ;
Helwig, U ;
Nitz, I ;
Hampe, J ;
Schreiber, S ;
Schrezenmeir, J ;
Döring, F .
MOLECULAR NUTRITION & FOOD RESEARCH, 2006, 50 (03) :270-274